Annual EBITDA
-$2.86B$897.00M+23.88%
Summary
- Current Value
- As of today, MRNA annual EBITDA is -$2.86B, up +23.88% on
- Historical Performance
- MRNA annual EBITDA is down -129.74% over the past 3 years, down -290.63% over the past 5 years
- All-Time High Comparison
- MRNA annual EBITDA is currently -121.22% below its historical high of $13.47B set on
- 3-Year Low Comparison
- MRNA annual EBITDA is +23.88% above its 3-year low of -$3.76B reached on
- Sector Comparison
- MRNA annual EBITDA is higher than 0.18% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$2.86B | +23.9% | -129.7% | -290.6% | -10000.0% | |
| Quarterly EBITDA | $198.00M | +195.2% | +111.2% | -94.5% | +4945.8% | |
| TTM EBITDA | -$2.67B | +17.9% | -20.4% | -134.4% | -10000.0% | |
| Price | $195.00 | +772.1% | +147.0% | -26.1% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $1.94B | -39.9% | -89.8% | +142.0% | +10000.0% | |
| Annual EPS | -$7.25 | +21.8% | -136.1% | -270.3% | +99.8% | |
| $0.00 | +100.0% | -100.0% | +100.0% | +100.0% | ||
| Annual Net Income | -$2.82B | +20.8% | -133.8% | -277.8% | -10000.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.61B | N/A | -129.7% |
| 5Y | $13.47B | -121.2% | |
| All | $13.47B | -121.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$3.76B | +23.9% | |
| 5Y | -$3.76B | +23.9% | |
| All | -$3.76B | +23.9% |
EBITDA History
FAQ
- What is the current annual EBITDA of MRNA?
- As of today, MRNA annual EBITDA is -$2.86B
- What is 1-year change in MRNA annual EBITDA?
- MRNA annual EBITDA is up +23.88% year-over-year
- What is 3-year change in MRNA annual EBITDA?
- MRNA annual EBITDA is down -129.74% over the past 3 years
- How far is MRNA annual EBITDA from its all-time high?
- MRNA annual EBITDA is currently -121.22% below its historical high of $13.47B set on December 31, 2021
- How does MRNA annual EBITDA rank versus sector peers?
- MRNA annual EBITDA is higher than 0.18% of companies in Healthcare sector
- When is MRNA next annual earnings release?
- The next annual earnings release for MRNA is on
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$198.00M$950.00M+126.33%
Summary
- Current Value
- As of today, MRNA quarterly EBITDA is $198.00M, up +126.33% on
- Historical Performance
- MRNA quarterly EBITDA is up +195.19% year-over-year, up +111.23% over the past 3 years
- All-Time High Comparison
- MRNA quarterly EBITDA is currently -96.35% below its historical high of $5.42B set on
- 3-Year Low Comparison
- MRNA quarterly EBITDA is +111.23% above its 3-year low of -$1.76B reached on an earlier date
- Sector Comparison
- MRNA quarterly EBITDA is higher than 90.77% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $198.00M | +126.3% | +195.2% | +111.2% | -94.5% | |
| Annual EBITDA | -$2.86B | – | +23.9% | -129.7% | -290.6% | |
| TTM EBITDA | -$2.67B | +13.2% | +17.9% | -20.4% | -134.4% | |
| Price | $195.00 | +46.3% | +772.1% | +147.0% | -26.1% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $1.31B | +805.5% | +29.2% | -28.3% | -73.6% | |
| Quarterly EPS | $0.38 | +119.3% | +173.9% | +104.0% | -95.1% | |
| $130.00M | +116.0% | +150.0% | +106.5% | -96.3% | ||
| Quarterly Net Income | $162.00M | +120.7% | +181.0% | +104.5% | -95.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $198.00M | at high | |
| 3Y | $200.00M | -1.0% | |
| 5Y | $5.42B | -96.3% | |
| All | $5.42B | -96.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$1.33B | +114.9% | |
| 3Y | -$1.76B | N/A | +111.2% |
| 5Y | -$1.78B | +111.1% | |
| All | -$1.78B | +111.1% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of MRNA?
- As of today, MRNA quarterly EBITDA is $198.00M
- What is MRNA quarterly EBITDA most recent change?
- MRNA quarterly EBITDA was up +126.33% on September 30, 2026
- What is 1-year change in MRNA quarterly EBITDA?
- MRNA quarterly EBITDA is up +195.19% year-over-year
- How far is MRNA quarterly EBITDA from its all-time high?
- MRNA quarterly EBITDA is currently -96.35% below its historical high of $5.42B set on December 31, 2021
- How does MRNA quarterly EBITDA rank versus sector peers?
- MRNA quarterly EBITDA is higher than 90.77% of companies in Healthcare sector
- When is MRNA next earnings release?
- The next earnings release for MRNA is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
-$2.67B$406.00M+13.19%
Summary
- Current Value
- As of today, MRNA TTM EBITDA is -$2.67B, up +13.19% on
- Historical Performance
- MRNA TTM EBITDA is up +17.88% year-over-year, down -20.41% over the past 3 years
- All-Time High Comparison
- MRNA TTM EBITDA is currently -116.23% below its historical high of $16.47B set on
- 3-Year Low Comparison
- MRNA TTM EBITDA is +41.51% above its 3-year low of -$4.57B reached on
- Sector Comparison
- MRNA TTM EBITDA is higher than 0.10% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$2.67B | +13.2% | +17.9% | -20.4% | -134.4% | |
| Annual EBITDA | -$2.86B | – | +23.9% | -129.7% | -290.6% | |
| Quarterly EBITDA | $198.00M | +126.3% | +195.2% | +111.2% | -94.5% | |
| Price | $195.00 | +46.3% | +772.1% | +147.0% | -26.1% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $2.53B | +13.3% | +13.1% | -72.2% | -78.7% | |
| TTM EPS | -$7.09 | +11.2% | +12.0% | +24.0% | -143.6% | |
| -$2.93B | +11.8% | +15.4% | -7.8% | -138.5% | ||
| TTM Net Income | -$2.79B | +11.5% | +10.5% | +19.5% | -139.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$2.67B | at high | |
| 3Y | -$2.22B | N/A | -20.4% |
| 5Y | $16.47B | -116.2% | |
| All | $16.47B | -116.2% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$3.26B | N/A | +17.9% |
| 3Y | -$4.57B | +41.5% | |
| 5Y | -$4.57B | +41.5% | |
| All | -$4.57B | +41.5% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of MRNA?
- As of today, MRNA TTM EBITDA is -$2.67B
- What is MRNA TTM EBITDA most recent change?
- MRNA TTM EBITDA was up +13.19% on September 30, 2026
- What is 1-year change in MRNA TTM EBITDA?
- MRNA TTM EBITDA is up +17.88% year-over-year
- How far is MRNA TTM EBITDA from its all-time high?
- MRNA TTM EBITDA is currently -116.23% below its historical high of $16.47B set on March 31, 2022
- How does MRNA TTM EBITDA rank versus sector peers?
- MRNA TTM EBITDA is higher than 0.10% of companies in Healthcare sector
- When is MRNA next earnings release?
- The next earnings release for MRNA is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- MRNA Official Website www.modernatx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000162828025053816/0001628280-25-053816-index.htm
- MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
- MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna
